Literature DB >> 29331355

Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation.

James V Freeman1, Grace H Tabada2, Kristi Reynolds3, Sue Hee Sung2, Taylor I Liu4, Nigel Gupta5, Alan S Go6.   

Abstract

Contemporary data on complications and resource utilization after atrial fibrillation (AF) ablation are limited. We evaluated rates and risk factors for procedural complication, rehospitalization, and emergency department visits after AF ablation. We identified all adult patients who underwent isolated AF ablation between 2010 and June 2014 in 2 large integrated health-care delivery systems and evaluated rates of acute inpatient complication, 30-day, and 1-year readmission and emergency evaluation. We used multivariable logistic regression to identify predictors of procedural complications, 30-day readmission, or 30-day emergency department evaluation. In 811 AF ablation patients, procedural complications occurred in 2.5% of patients, 9.7% of patients were rehospitalized within 30 days, and 19.1% of patients had an emergency visit within 30 days. At 1 year after AF ablation, 28.9% of patients were readmitted, with 18% of patients readmitted for AF or atrial flutter. At 1 year, 44.5% of patients were seen in an emergency department, with 37.1% related to AF or atrial flutter. Vascular complications and perforation or tamponade were the most common complications, and Hispanic ethnicity, mitral or aortic valvular disease, and diabetes mellitus were the strongest risk factors for adverse outcomes at 30 days after AF ablation. Contemporary rates of acute complication and 1-year readmission after AF ablation have markedly decreased compared with previous community-based studies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29331355      PMCID: PMC5805603          DOI: 10.1016/j.amjcard.2017.11.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

Authors:  Alan S Go; Jingrong Yang; Lynn M Ackerson; Krista Lepper; Sean Robbins; Barry M Massie; Michael G Shlipak
Journal:  Circulation       Date:  2006-06-05       Impact factor: 29.690

2.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

3.  The California Automated Mortality Linkage System (CAMLIS).

Authors:  M G Arellano; G R Petersen; D B Petitti; R E Smith
Journal:  Am J Public Health       Date:  1984-12       Impact factor: 9.308

4.  Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent.

Authors:  P D McGrath; D E Wennberg; J D Dickens; A E Siewers; F L Lucas; D J Malenka; M A Kellett; T J Ryan
Journal:  JAMA       Date:  2000-12-27       Impact factor: 56.272

5.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

6.  Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.

Authors:  Francesco Grigioni; Jean-François Avierinos; Lieng H Ling; Christopher G Scott; Kent R Bailey; A Jamil Tajik; Robert L Frye; Maurice Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

7.  Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries.

Authors:  Ethan R Ellis; Steven D Culler; April W Simon; Matthew R Reynolds
Journal:  Heart Rhythm       Date:  2009-06-06       Impact factor: 6.343

8.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 10.  Impact of Contact Force Technology on Atrial Fibrillation Ablation: A Meta-Analysis.

Authors:  Mohammed Shurrab; Luigi Di Biase; David F Briceno; Anna Kaoutskaia; Saleem Haj-Yahia; David Newman; Ilan Lashevsky; Hiroshi Nakagawa; Eugene Crystal
Journal:  J Am Heart Assoc       Date:  2015-09-21       Impact factor: 5.501

View more
  8 in total

1.  Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications.

Authors:  James V Freeman; Grace H Tabada; Kristi Reynolds; Sue Hee Sung; Daniel E Singer; Paul J Wang; Taylor I Liu; Nigel Gupta; Mark A Hlatky; Alan S Go
Journal:  Am J Cardiol       Date:  2019-11-19       Impact factor: 2.778

Review 2.  Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Authors:  M Matta; A Saglietto; P De Salvo; A Bissolino; A Ballatore; M Anselmino
Journal:  Herz       Date:  2019-05       Impact factor: 1.443

3.  Safety and Efficacy of Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Diabetic Patients.

Authors:  Abdin Amr; Heeger Christian-H; Yalin Kivanc; Santoro Francesco; Brunetti Natale Daniele; Fink Thomas; Liosis Spyridon; Brueggemann Ben; Keelani Ahmad; Phan Huong Lan; Sano Makoto; Sciacca Vanessa; Lyan Evgeny; A N Dong; Meyer-Saraei Roza; Ouyang Feifan; Kuck Karl-Heinz; Eitel Charlotte; Vogler Julia; Tilz Roland Richard
Journal:  J Atr Fibrillation       Date:  2020-04-30

4.  Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter-Based Atrial Fibrillation Ablation: A Population-Based Cohort Study From Ontario, Canada.

Authors:  Andrew C T Ha; Harindra C Wijeysundera; Feng Qiu; Kayley Henning; Kamran Ahmad; Paul Angaran; David H Birnie; Eugene Crystal; Andrew H Ha; Jeff S Healey; Peter Leong-Sit; Bhavanesh Makanjee; Pablo B Nery; Damian P Redfearn; Allan C Skanes; Atul Verma
Journal:  J Am Heart Assoc       Date:  2020-12-31       Impact factor: 5.501

5.  Causes and Predictors of Readmission in Patients With Atrial Fibrillation Undergoing Catheter Ablation: A National Population-Based Cohort Study.

Authors:  Shilpkumar Arora; Sopan Lahewala; Byomesh Tripathi; Varshil Mehta; Varun Kumar; Divya Chandramohan; Alejandro Lemor; Mihir Dave; Nileshkumar Patel; Nilay V Patel; Ghanshyam Palamaner Subash Shantha; Juan Viles-Gonzalez; Abhishek Deshmukh
Journal:  J Am Heart Assoc       Date:  2018-06-15       Impact factor: 5.501

6.  Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology.

Authors:  Joseph G Akar; James P Hummel; Xiaoxi Yao; Lindsey Sangaralingham; Sanket Dhruva; Jun Dong; Rebecca Ward; Nilay D Shah; Joseph Ross; Peter A Noseworthy
Journal:  BMJ Surg Interv Health Technol       Date:  2020-12-29

Review 7.  Impact of Catheter Ablation on Quality of Life and Healthcare Utilisation.

Authors:  Sanghamitra Mohanty; Andrea Natale
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-12

8.  Comparative Safety and Effectiveness of Sotalol Versus Dronedarone After Catheter Ablation for Atrial Fibrillation.

Authors:  John Marcus Wharton; Jonathan P Piccini; Andrew Koren; Samuel Huse; Christopher J Ronk
Journal:  J Am Heart Assoc       Date:  2022-01-21       Impact factor: 6.106

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.